arl_stat
★

India,
2020-10-14 08:39
(1431 d 14:55 ago)

Posting: # 21996
Views: 3,560

## Parallel design from crossover CV [Power / Sample Size]

Greetings to all !!

Hope all of you are safe in this pandemic situation.

Mostly in public domain, the inter subject CV of drug is not mentioned. Either intra-subject cv or confidence interval ranges are mentioned. So can we use this intra-subject CV to estimate sample size for parallel study design?

Is there any formula to calculate inter-subject CV using 90% confidence interval ranges and number of subjects?

First can we calculate the sample size of 2 way crossover study design and then double the subjects and finalize the sample size for parallel study design?

Stay Safe.

Thank You

Helmut
★★★

Vienna, Austria,
2020-10-14 13:00
(1431 d 10:34 ago)

@ arl_stat
Posting: # 21998
Views: 2,953

## No relationship between inter- and intra-subject CV

Hi arl_stat,

❝ Mostly in public domain, the inter subject CV of drug is not mentioned.

You fell into trap of wrong terminology. Even if a study was performed in a parallel design, one gets the total (a.k.a. pooled) CV – not the inter-subject CV.$$CV_{\textrm{total}}=\sqrt{\exp\left(\log_{e}(CV_{\textrm{inter}}^{2}+1)+\log_{e}(CV_{\textrm{intra}}^{2}+1)\right)-1}\tag{1}$$
Simply: The total variance (which you observe in any design) is the sum of inter- and intra-subject variances.$$s_{\textrm{total}}^{2}=s_{\textrm{inter}}^{2}+s_{\textrm{intra}}^{2}\tag{2}$$ The inter-subject CV is only accessible in a crossover study (see this post).

❝ […] can we use this intra-subject CV to estimate sample size for parallel study design?

No.

❝ Is there any formula to calculate inter-subject CV using 90% confidence interval ranges and number of subjects?

No, since you need the CVtotal calculated acc. to $$(1)$$ from a crossover – or directly observed in a parallel design – and there is no relationship between CVinter and CVintra. Hence, CVintra from a crossover alone does not help.

❝ First can we calculate the sample size of 2 way crossover study design and then double the subjects and finalize the sample size for parallel study design?

No (see above). For ages rumors are swirling around a factor of two but that’s plain nonsense. Think about a drug with low CVintra and polymorphic metabolism. Then the factor can easily be >5 and by doubling the sample size of a crossover the parallel study will be grossly underpowered. BTW, in rare cases CVintra > CVinter.

Run a – not too small! – pilot study or a TSD.*

Dif-tor heh smusma 🖖🏼 Довге життя Україна!
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
arl_stat
★

India,
2020-10-14 17:02
(1431 d 06:32 ago)

@ Helmut
Posting: # 22001
Views: 2,878

## No relationship between inter- and intra-subject CV

Thank you so much sir for your quick response and guidance.
23,225 posts in 4,879 threads, 1,652 registered users;
37 visitors (0 registered, 37 guests [including 7 identified bots]).
Forum time: 23:35 CEST (Europe/Vienna)

We absolutely must leave room for doubt
or there is no progress and no learning.
There is no learning without having to pose a question.
And a question requires doubt.
People search for certainty.
But there is no certainty.    Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
Ing. Helmut Schütz